Early Response to First-Line Anti–PD-1 Treatment in Hodgkin Lymphoma: A PET-Based Analysis from the Prospective, Randomized Phase II NIVAHL Trial
暂无分享,去创建一个
M. Dietlein | C. Kobe | P. Borchmann | A. Engert | M. Fuchs | U. Keller | P. Bröckelmann | J. Meissner | B. von Tresckow | C. Baues | S. Sasse | K. Trautmann-Grill | H. Goergen | H. Müller | L. van Heek | A. Kerkhoff | J. Mettler | C. Voltin